Biotech Values

[willyw]

lots of rises and falls. : )

And falls and falls. : )

When you look at the volume it's easy to surmise that Enanta is rather off the radar- even in the past during better days.

I take some comfort in knowing that they have an excellent background in virology. (see HCV)
I think that this was also shown in HBV.
For me it looks like it is potentially a best in class in Covid antivirals.

The stock currently is low because- well lots of things are low now, right?
But I also think that the covid market is undervalued for a variety of reasons.
As per the conversation this morning about VRUS/HCV Mr. Market isn't always right..

I wonder if it's a little like Viking (VKTX). 11 months ago it was trading at $2.22;
$16.39 right now.
Well, I can dream, : )